After @ weeks ' treatment , the @-mg dose demonstrated minimal efficacy ( HbA@c -@ @ % ) and the @-mg dose demonstrated near-maximal efficacy ( HbA@c -@ @ % ) , which was not statistically different from the efficacy of @ mg pioglitazone ( HbA@c -@ @ % ; P < @ for noninferiority ) .